Status:
COMPLETED
Vascular Anomaly Pathology and Genomics Biopsy Study
Lead Sponsor:
Mayo Clinic
Conditions:
Vascular Malformations
Vascular Anomaly
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The purpose of this research is to gather information on the safety and effectiveness of core biopsy of vascular anomalies for clinical pathology and clinical genomics studies.
Detailed Description
Vascular anomalies or vascular malformations often are treated with minimally invasive sclerotherapy, embolization or ablation based on clinical and imaging features without acquisition of tissue. Ove...
Eligibility Criteria
Inclusion
- Patients with a clinical and imaging diagnosis of a vascular anomaly.
- No prior treatment for the vascular anomaly.
- Subjects undergoing clinically indicated sclerotherapy, embolization and/or ablation.
- Male or female with age greater than or equal to 18 years.
- Capacity and willingness to provide a written informed consent..
Exclusion
- Subjects with prior treatment for their vascular anomaly.
- Uncorrectable coagulopathy.
- Pregnant and/or breast-feeding subjects. A negative pregnancy test within 48 hours of the procedure.
Key Trial Info
Start Date :
April 6 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 31 2022
Estimated Enrollment :
3 Patients enrolled
Trial Details
Trial ID
NCT04836884
Start Date
April 6 2021
End Date
January 31 2022
Last Update
April 21 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mayo Clinic in Rochester
Rochester, Minnesota, United States, 55905